A citation-based method for searching scientific literature

Jesper Ekelund, Mark Slifstein, Raj Narendran, Olivier Guillin, Hemant Belani, Ning-Ning Guo, Yuying Hwang, Dah-Ren Hwang, Anissa Abi-Dargham, Marc Laruelle. Mol Imaging Biol 2007
Times Cited: 67







List of co-cited articles
809 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


[11C]NNC 112 selectivity for dopamine D1 and serotonin 5-HT(2A) receptors: a PET study in healthy human subjects.
Mark Slifstein, Lawrence S Kegeles, Robyn Gonzales, William G Frankle, Xiaoyan Xu, Marc Laruelle, Anissa Abi-Dargham. J Cereb Blood Flow Metab 2007
39
76

Prefrontal dopamine D1 receptors and working memory in schizophrenia.
Anissa Abi-Dargham, Osama Mawlawi, Ilise Lombardo, Roberto Gil, Diana Martinez, Yiyun Huang, Dah-Ren Hwang, John Keilp, Lisa Kochan, Ronald Van Heertum,[...]. J Neurosci 2002
500
34

Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain.
H Hall, G Sedvall, O Magnusson, J Kopp, C Halldin, L Farde. Neuropsychopharmacology 1994
304
32

Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.
Y Okubo, T Suhara, K Suzuki, K Kobayashi, O Inoue, O Terasaki, Y Someya, T Sassa, Y Sudo, E Matsushima,[...]. Nature 1997
517
29

Consensus nomenclature for in vivo imaging of reversibly binding radioligands.
Robert B Innis, Vincent J Cunningham, Jacques Delforge, Masahiro Fujita, Albert Gjedde, Roger N Gunn, James Holden, Sylvain Houle, Sung-Cheng Huang, Masanori Ichise,[...]. J Cereb Blood Flow Metab 2007
29

Simplified reference tissue model for PET receptor studies.
A A Lammertsma, S P Hume. Neuroimage 1996
29

PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia.
Per Karlsson, Lars Farde, Christer Halldin, Göran Sedvall. Am J Psychiatry 2002
122
26

Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors.
C Halldin, C Foged, Y H Chou, P Karlsson, C G Swahn, J Sandell, G Sedvall, L Farde. J Nucl Med 1998
80
23

Increased prefrontal cortical D₁ receptors in drug naive patients with schizophrenia: a PET study with [¹¹C]NNC112.
Anissa Abi-Dargham, Xiaoyan Xu, Judy L Thompson, Roberto Gil, Lawrence S Kegeles, Nina Urban, Raj Narendran, Dah-Ren Hwang, Marc Laruelle, Mark Slifstein. J Psychopharmacol 2012
90
23

Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: validation and reproducibility.
A Abi-Dargham, D Martinez, O Mawlawi, N Simpson, D R Hwang, M Slifstein, S Anjilvel, J Pidcock, N N Guo, I Lombardo,[...]. J Cereb Blood Flow Metab 2000
121
20


Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophrenia.
Ningning Guo, Dah-Ren Hwang, Ee-Sing Lo, Yung-Yu Huang, Marc Laruelle, Anissa Abi-Dargham. Neuropsychopharmacology 2003
63
20

Imaging cortical dopamine D1 receptors using [11C]NNC112 and ketanserin blockade of the 5-HT 2A receptors.
Ana M Catafau, Graham E Searle, Santiago Bullich, Roger N Gunn, Eugenii A Rabiner, Raul Herance, Joaquim Radua, Magi Farre, Marc Laruelle. J Cereb Blood Flow Metab 2010
17
76

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method.
A Breier, T P Su, R Saunders, R E Carson, B S Kolachana, A de Bartolomeis, D R Weinberger, N Weisenfeld, A K Malhotra, W C Eckelman,[...]. Proc Natl Acad Sci U S A 1997
873
17

Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography.
C Halldin, S Stone-Elander, L Farde, E Ehrin, K J Fasth, B Långström, G Sedvall. Int J Rad Appl Instrum A 1986
90
16

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.
A Abi-Dargham, J Rodenhiser, D Printz, Y Zea-Ponce, R Gil, L S Kegeles, R Weiss, T B Cooper, J J Mann, R L Van Heertum,[...]. Proc Natl Acad Sci U S A 2000
673
14

Altered prefrontal dopaminergic function in chronic recreational ketamine users.
Rajesh Narendran, W Gordon Frankle, Richard Keefe, Roberto Gil, Diana Martinez, Mark Slifstein, Lawrence S Kegeles, Peter S Talbot, Yiyun Huang, Dah-Ren Hwang,[...]. Am J Psychiatry 2005
100
14

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients.
A L Nordström, L Farde, F A Wiesel, K Forslund, S Pauli, C Halldin, G Uppfeldt. Biol Psychiatry 1993
392
14

Brain dopamine d1 receptors in twins discordant for schizophrenia.
Jussi Hirvonen, Theo G M van Erp, Jukka Huttunen, Sargo Aalto, Kjell Någren, Matti Huttunen, Jouko Lönnqvist, Jaakko Kaprio, Tyrone D Cannon, Jarmo Hietala. Am J Psychiatry 2006
46
21

Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort.
A Abi-Dargham, R Gil, J Krystal, R M Baldwin, J P Seibyl, M Bowers, C H van Dyck, D S Charney, R B Innis, M Laruelle. Am J Psychiatry 1998
561
14

Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum.
O Mawlawi, D Martinez, M Slifstein, A Broft, R Chatterjee, D R Hwang, Y Huang, N Simpson, K Ngo, R Van Heertum,[...]. J Cereb Blood Flow Metab 2001
435
14

In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice.
Eugenii A Rabiner, Mark Slifstein, Jose Nobrega, Christophe Plisson, Mickael Huiban, Roger Raymond, Mustansir Diwan, Alan A Wilson, Patrick McCormick, Gabriella Gentile,[...]. Synapse 2009
111
14

Decreased binding of [11C]NNC112 and [11C]SCH23390 in patients with chronic schizophrenia.
Jun Kosaka, Hidehiko Takahashi, Hiroshi Ito, Akihiro Takano, Yota Fujimura, Ryohei Matsumoto, Shoko Nozaki, Fumihiko Yasuno, Yoshiro Okubo, Toshifumi Kishimoto,[...]. Life Sci 2010
38
26

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.
M Laruelle, A Abi-Dargham, C H van Dyck, R Gil, C D D'Souza, J Erdos, E McCance, W Rosenblatt, C Fingado, S S Zoghbi,[...]. Proc Natl Acad Sci U S A 1996
923
13

Elevated dopa decarboxylase activity in living brain of patients with psychosis.
J Reith, C Benkelfat, A Sherwin, Y Yasuhara, H Kuwabara, F Andermann, S Bachneff, P Cumming, M Diksic, S E Dyve,[...]. Proc Natl Acad Sci U S A 1994
239
13

6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography.
A M Elkashef, D Doudet, T Bryant, R M Cohen, S H Li, R J Wyatt. Psychiatry Res 2000
75
13

Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET.
L H Lindström, O Gefvert, G Hagberg, T Lundberg, M Bergström, P Hartvig, B Långström. Biol Psychiatry 1999
196
13

A PET study of D(1)-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brain.
Y H Chou, P Karlsson, C Halldin, H Olsson, L Farde. Psychopharmacology (Berl) 1999
57
15

NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists.
P H Andersen, F C Grønvald, R Hohlweg, L B Hansen, E Guddal, C Braestrup, E B Nielsen. Eur J Pharmacol 1992
76
13

Elevated striatal dopamine function linked to prodromal signs of schizophrenia.
Oliver D Howes, Andrew J Montgomery, Marie-Claude Asselin, Robin M Murray, Isabel Valli, Paul Tabraham, Elvira Bramon-Bosch, Lucia Valmaggia, Louise Johns, Matthew Broome,[...]. Arch Gen Psychiatry 2009
479
13

Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography.
Alan A Wilson, Patrick McCormick, Shitij Kapur, Matthaeus Willeit, Armando Garcia, Doug Hussey, Sylvain Houle, Philip Seeman, Nathalie Ginovart. J Med Chem 2005
187
13


Dopamine D(1) receptors and age differences in brain activation during working memory.
Lars Bäckman, Sari Karlsson, Håkan Fischer, Per Karlsson, Yvonne Brehmer, Anna Rieckmann, Stuart W S MacDonald, Lars Farde, Lars Nyberg. Neurobiol Aging 2011
74
13


Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457.
Mirjam Talvik, Anna-Lena Nordström, Hans Olsson, Christer Halldin, Lars Farde. Int J Neuropsychopharmacol 2003
91
11

Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia.
Tetsuya Suhara, Yoshiro Okubo, Fumihiko Yasuno, Yasuhiko Sudo, Makoto Inoue, Tetsuya Ichimiya, Yoshifumi Nakashima, Kazuhiko Nakayama, Shuji Tanada, Kazutoshi Suzuki,[...]. Arch Gen Psychiatry 2002
133
11


Presynaptic dopaminergic function in the striatum of schizophrenic patients.
M H Dao-Castellana, M L Paillère-Martinot, P Hantraye, D Attar-Lévy, P Rémy, C Crouzel, E Artiges, A Féline, A Syrota, J L Martinot. Schizophr Res 1997
117
11

Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.
J Hietala, E Syvälahti, K Vuorio, V Räkköläinen, J Bergman, M Haaparanta, O Solin, M Kuoppamäki, O Kirvelä, U Ruotsalainen. Lancet 1995
245
11


Increased dopamine transmission in schizophrenia: relationship to illness phases.
M Laruelle, A Abi-Dargham, R Gil, L Kegeles, R Innis. Biol Psychiatry 1999
495
11


Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia.
J Hietala, E Syvälahti, H Vilkman, K Vuorio, V Räkköläinen, J Bergman, M Haaparanta, O Solin, M Kuoppamäki, E Eronen,[...]. Schizophr Res 1999
176
11

Age-dependent decline of dopamine D1 receptors in human brain: a PET study.
Y Wang, G L Chan, J E Holden, T Dobko, E Mak, M Schulzer, J M Huser, B J Snow, T J Ruth, D B Calne,[...]. Synapse 1998
154
11

Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide.
Anissa Abi-Dargham, Lawrence S Kegeles, Yolanda Zea-Ponce, Osama Mawlawi, Diana Martinez, Vivian Mitropoulou, Karen O'Flynn, Harold W Koenigsberg, Ronald Van Heertum, Thomas Cooper,[...]. Biol Psychiatry 2004
80
11

The dopamine D2 receptors in high-affinity state and D3 receptors in schizophrenia: a clinical [11C]-(+)-PHNO PET study.
Ariel Graff-Guerrero, Romina Mizrahi, Ofer Agid, Heidi Marcon, Penny Barsoum, Pablo Rusjan, Alan A Wilson, Robert Zipursky, Shitij Kapur. Neuropsychopharmacology 2009
78
11

Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
Rajesh Narendran, Mark Slifstein, Olivier Guillin, Yuying Hwang, Dah-Ren Hwang, Erica Scher, Stephanie Reeder, Eugenii Rabiner, Marc Laruelle. Synapse 2006
137
11

COMT genotype predicts cortical-limbic D1 receptor availability measured with [11C]NNC112 and PET.
M Slifstein, B Kolachana, E H Simpson, P Tabares, B Cheng, M Duvall, W Gordon Frankle, D R Weinberger, M Laruelle, A Abi-Dargham. Mol Psychiatry 2008
141
11

Changes in cortical dopamine D1 receptor binding associated with cognitive training.
Fiona McNab, Andrea Varrone, Lars Farde, Aurelija Jucaite, Paulina Bystritsky, Hans Forssberg, Torkel Klingberg. Science 2009
297
11

Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study.
T D L Steeves, J Miyasaki, M Zurowski, A E Lang, G Pellecchia, T Van Eimeren, P Rusjan, S Houle, A P Strafella. Brain 2009
336
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.